EFFICIENCY AND SAFETY OF NEURAMINIDASE INHIBITOR OSELTAMIVIR FOR CHILDREN
Every year 3 to 5 million people suffer from flu. Children are most susceptible to flu. At the moment, the main methods of flu prophylaxis and treatment are flu vaccination and antivirus medications. Of the tested anti virus medications, 3 groups are most interesting and interferon inductors, м 2=ch...
Saved in:
| Main Author: | A.S. Darmanyan |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2007-10-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/727 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OSELTAMIVIR IN FLU TREATMENT AND PREVENTION AMONG CHILDREN
by: T.V. Kulichenko, et al.
Published: (2007-12-01) -
Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.
by: Jeff Butler, et al.
Published: (2014-04-01) -
OPPORTUNITIES FOR APPLICATION OF THE NEURAMINIDASE INHIBITORS IN TREATMENT AND PREVENTION OF THE FLU
by: Yu.B. Belan, et al.
Published: (2007-08-01) -
Neuraminidase reassortment and oseltamivir resistance in clade 2.3.4.4b A(H5N1) viruses circulating among Canadian poultry, 2024
by: Anthony V. Signore, et al.
Published: (2025-12-01) -
Effects of vaccination and the new neuraminidase inhibitor, laninamivir, on influenza infection.
by: Takuro Mizuno, et al.
Published: (2014-01-01)